Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Hematopoietic Stem Cell Transplantation (HSCT) Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Hematopoietic Stem Cell Transplantation (HSCT) Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering
Stem cell-based regenerative and cellular medicine can be used to regenerate and repair diseased or damaged tissues in people. To address the education and training gaps in area of regenerative medicine, Maharashtra University of Health Sciences (MUHS), Nashik has been granted first affiliation to conduct a fellowship course in regenerative medicine and stem cell-based therapies on research basis at Dr. Mahajans Hospital and Stem Rx Bioscience Solution Pvt Ltd, Navi Mumbai
DUARTE, Calif.--(BUSINESS WIRE)--Researchers led by City of Hope, a world-renowned research and treatment center for cancer, diabetes and other life-threatening diseases, have developed a powerful miniature brain platform to study the mechanistic causes of Alzheimers disease and to test dementia drugs in development, reports a new study published today in Advanced Science. Drug development for Alzheimers disease has run into challenges due to incomplete understanding of the diseases pathological mechanisms, said Yanhong Shi, Ph.D., the Herbert Horvitz Professor in Neuroscience and director of the Division of Stem Cell Biology Research within the Department of Developmental and Stem Cell Biology at Beckman Research Institute of City of Hope. Preclinical research in this arena predominantly uses animal models, but there is a huge difference between humans and animals such as rodents, especially when it comes to brain architecture
The Daily sat down with James Won Suk Jahng, a Stanford postdoctoral student, and one of four postdoctoral students in the United States picked for a Translational Research Institute for Space Health (TRISH) fellowship.The fellowship works to collaborate with researchers to design biomedical technology for astronaut safety and apply them for future space missions. Jahng who grew up in Korea before immigrating to Canada and later the United States is interested in both space health as well as mitochondria, popularly known as the powerhouse of the cell
You are here: 02 August 2021 Professor Roger Daly The first award under BioCurates new Proof of Concept fund has been granted to the Monash Biomedicine Discovery Institute (BDI). This award will support the key research needed to determine the effectiveness of targeting two proteins that could lead to novel, targeted treatments for triple negative breast cancer (TNBC) and other poor prognosis cancers.
Kristie L. Kahl: Why is it important to help elevate the patient's voice when it comes to MPNs specifically? Brandon Getzman: Yeah, so, you know, the, there's 300,000, we believe there's 3000 MPN patients in the United States, and at least that in Europe, and so when you, when you think about the prevalence of this disease, just in those two regions of the world, there's, there's literally millions of MPN patients around the globe.
One potential treatment for multiple myeloma is a stem cell transplant. This involves a person receiving high-dose chemotherapy to kill the cancer cells in the bone marrow. This can also kill healthy cells inside the bone marrow, so the person then receives new, healthy, blood-forming stem cells via a transplant.
Stem cell research holds great potential for regenerative therapies and treatments to combat cardiovascular disease, which is responsible for over 30% of all deaths worldwide. Highly functional cardiomyocytes-;the muscle cells responsible for the contraction of the heart-;are important for disease modeling, drug screening, and other regenerative medicine approaches
Cardiovascular diseases account for 32% of global deaths.
bluebird bio and National Resilience signed a strategic alliance around cell therapies. As part of the deal, Resilience is buying bluebirds manufacturing facility in Research Triangle Park, keeping more than 100 staffers. Resilience will also continue supplying gene and cell therapy vectors for bluebird bio and 2seventy bio, bluebirds oncology cell therapy spinoff that is expected to launch by the end of the year.
Recent Comments